Katia Hamidouche

Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances

V. Bouet, T. Freret, M. Boulouard, 2015, Behavioural Brain Research.

Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.

T. Freret, M. Boulouard, Céline Ballandonne, 2016, European journal of medicinal chemistry.

Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.

S. Corvaisier, Rémi Legay, V. Bouet, 2015, Journal of medicinal chemistry.

Donecopride, a Swiss army knife with potential against Alzheimer's disease

J. Bockaert, S. Rivera, T. Freret, 2019, British journal of pharmacology.

Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse

V. Lelong-Boulouard, T. Freret, F. Dauphin, 2017, Psychopharmacology.

Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse

V. Lelong-Boulouard, T. Freret, F. Dauphin, 2017, Psychopharmacology.